Cosmos Health (COSM) Current Leases (2019 - 2026)
Cosmos Health's (COSM) quarterly Current Leases came in at $205140.0 in Q2 2026, down 4.88% on a YoY basis from $215665.0 in Q2 2025, and little changed quarter-over-quarter from $204588.0 in Q1 2026.
Powered by 
Analysis
Cosmos Health (COSM) Current Leases (2019 - 2026) Analysis & Trends
Cosmos Health (COSM) has reported Current Leases for 8 consecutive years, with $205140.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Current Leases fell 4.88% year-over-year to $205140.0; the trailing twelve-month figure through Jun 2026 stood at $205140.0 (down 4.88% YoY), and the FY2025 full-year result was $222115.0, up 12.91% from the prior year.
- Current Leases was little changed at $205140.0 in Q2 2026 per COSM's latest filing, from $204588.0 in the prior quarter.
- Across five years, Current Leases topped out at $285563.0 in Q4 2023 and bottomed at $134833.0 in Q2 2022.
- Historically, Current Leases has averaged $207912.1 across 5 years, with a median of $204864.0 in 2026.
- The sharpest annual moves came in 2022 and 2024: Current Leases surged 73.27% in 2022, then sank 31.11% in 2024.
- Over 5 years, Current Leases stood at $239899.0 in 2022, then rose by 19.03% to $285563.0 in 2023, then sank by 31.11% to $196718.0 in 2024, then climbed by 12.91% to $222115.0 in 2025, then fell by 7.64% to $205140.0 in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $205140.0, $204588.0, and $222115.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn | 9.04 Mn |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | 11.82 Mn |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn | 8.80 Mn |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn | - |
| 10 | Cosmos Health | 15.08 Mn | 12.63 Mn | 1.51 Mn | 205,140.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 205,140.00 |
| Mar 31, 2026 | 204,588.00 |
| Dec 31, 2025 | 222,115.00 |
| Sep 30, 2025 | 224,821.00 |
| Jun 30, 2025 | 215,665.00 |
| Mar 31, 2025 | 203,601.00 |
| Dec 31, 2024 | 196,718.00 |
| Sep 30, 2024 | 241,422.00 |
| Jun 30, 2024 | 254,255.00 |
| Mar 31, 2024 | 262,967.00 |
| Dec 31, 2023 | 285,563.00 |
| Sep 30, 2023 | 169,500.00 |
| Jun 30, 2023 | 171,728.00 |
| Mar 31, 2023 | 195,812.00 |
| Dec 31, 2022 | 239,899.00 |
| Sep 30, 2022 | 155,432.00 |
| Jun 30, 2022 | 134,833.00 |
| Mar 31, 2022 | 158,359.00 |
| Dec 31, 2021 | 138,450.00 |
| Sep 30, 2021 | 173,801.00 |